Clinical trial
Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)
NCT06883643 is registered in ClinicalTrials.gov with Centre for Infectious Disease Research in Zambia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)
- Lead sponsor
- Centre for Infectious Disease Research in Zambia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 4, 2022
- Completion date
- March 31, 2023
- Enrollment
- 3,318 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
focus of the study is to evaluate dsd models for both tb treatment and tpt usiing key performance indicators